This might suggest that CTLA4Ig-modified DCs improve asthma, but not via Th1 cells, although we are not sure why OVA, OVA+rAdV-CTLA4Ig, and OVA+rAdV-GFP-modified DC transplantation induced similar IFN-γ changes in mice. Here, IFNG is linked to asthma.